Influence of Nanocluster Molybdenum Polyoxometalates on the Morphofunctional State of Fibroblasts in Culture
- Authors: Ostroushko A.A.1, Ulitko M.V.1,2, Tonkushina M.O.1, Zubarev I.V.1, Medvedeva S.Y.1,3, Danilova I.G.1,3, Gubaeva O.V.1,2, Gagarin I.D.1, Gette I.F.1,3
-
Affiliations:
- Yeltsin Ural Federal University
- Institute of Medical Cell Technologies
- Institute of Immunology and Physiology, Ural Branch
- Issue: Vol 13, No 1-2 (2018)
- Pages: 1-10
- Section: Article
- URL: https://journals.rcsi.science/2635-1676/article/view/220335
- DOI: https://doi.org/10.1134/S199507801801010X
- ID: 220335
Cite item
Abstract
For the culture of normal and transformed fibroblasts, the differential effect of two nanoclusters (Мо72Fe30, Мо132) has been shown. The Мо72Fe30 nanocluster is nontoxic to normal fibroblasts, while the Мо132 cluster shows toxicity to normal and transformed fibroblasts. An analysis of the ultrastructure of the cells under the influence of the nanoclusters has demonstrated the specificity of the changes. The dermal fibroblasts are more resistant to the action of Мо72Fe30; the Мо132 cluster causes extensive disorders in the membrane organelles both in normal and transformed fibroblasts. The results confirm the possibility of applying the Мо72Fe30 nanocluster in biomedicine and the use of the Мо132 nanocluster in oncology.
About the authors
A. A. Ostroushko
Yeltsin Ural Federal University
Email: ig-danilova@yandex.ru
Russian Federation, Yekaterinburg, 620002
M. V. Ulitko
Yeltsin Ural Federal University; Institute of Medical Cell Technologies
Email: ig-danilova@yandex.ru
Russian Federation, Yekaterinburg, 620002; Yekaterinburg, 620026
M. O. Tonkushina
Yeltsin Ural Federal University
Email: ig-danilova@yandex.ru
Russian Federation, Yekaterinburg, 620002
I. V. Zubarev
Yeltsin Ural Federal University
Email: ig-danilova@yandex.ru
Russian Federation, Yekaterinburg, 620002
S. Yu. Medvedeva
Yeltsin Ural Federal University; Institute of Immunology and Physiology, Ural Branch
Email: ig-danilova@yandex.ru
Russian Federation, Yekaterinburg, 620002; Yekaterinburg, 620219
I. G. Danilova
Yeltsin Ural Federal University; Institute of Immunology and Physiology, Ural Branch
Author for correspondence.
Email: ig-danilova@yandex.ru
Russian Federation, Yekaterinburg, 620002; Yekaterinburg, 620219
O. V. Gubaeva
Yeltsin Ural Federal University; Institute of Medical Cell Technologies
Email: ig-danilova@yandex.ru
Russian Federation, Yekaterinburg, 620002; Yekaterinburg, 620026
I. D. Gagarin
Yeltsin Ural Federal University
Email: ig-danilova@yandex.ru
Russian Federation, Yekaterinburg, 620002
I. F. Gette
Yeltsin Ural Federal University; Institute of Immunology and Physiology, Ural Branch
Email: ig-danilova@yandex.ru
Russian Federation, Yekaterinburg, 620002; Yekaterinburg, 620219
Supplementary files
